Inogen Aktie
WKN DE: A1XB32 / ISIN: US45780L1044
04.11.2022 01:49:00
|
Inogen to Present at Upcoming Investor Conferences in November 2022
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following investor conferences:
- Stifel 2022 Healthcare Conference on Tuesday, November 15 at 10:20 a.m. Eastern Time
- Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30 at 11:30 a.m. Eastern Time
A live webcast and archived recording of each presentation will be available to all interested parties through the News / Events page on the Inogen Investor Relations website.
Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.
About Inogen
Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. The Company primarily develops, manufactures, and markets innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
For more information, please visit www.inogen.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221103006411/en/

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Inogen Incmehr Nachrichten
06.05.25 |
Ausblick: Inogen informiert über die jüngsten Quartalsergebnisse (finanzen.net) | |
22.04.25 |
Erste Schätzungen: Inogen öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) | |
24.02.25 |
Ausblick: Inogen legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net) | |
10.02.25 |
Erste Schätzungen: Inogen gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net) |
Analysen zu Inogen Incmehr Analysen
Aktien in diesem Artikel
Inogen Inc | 5,90 | 13,46% |
|